Continued medical management of drug-resistant epilepsy: implications for surgical consideration
- PMID: 27594401
- PMCID: PMC5244427
- DOI: 10.1111/epi.13489
Continued medical management of drug-resistant epilepsy: implications for surgical consideration
Conflict of interest statement
The author has no conflict of interest to disclose. I confirm that I have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.
Comment in
-
In response: Drug-resistant epilepsy in adults: outcome trajectories after failure of two medications.Epilepsia. 2016 Sep;57(9):1526-7. doi: 10.1111/epi.13487. Epilepsia. 2016. PMID: 27594402 No abstract available.
Comment on
-
Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications.Epilepsia. 2016 Jul;57(7):1152-60. doi: 10.1111/epi.13406. Epub 2016 Jun 6. Epilepsia. 2016. PMID: 27265407
References
-
- Choi H, Hayat MJ, Zhang R, et al. Drug-resistant epilepsy in adults: outcome trajectories after failure of two medications. Epilepsia. 2016;57:1152–1160. - PubMed
-
- Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–319. - PubMed
-
- Choi H, Sell RL, Lenert L, et al. Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA. 2008;300:2497–2505. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
